Radial Artery Catheterization for Percutaneous Vascular or Coronary Interventions: An Innocent Procedure?

Yan Z. , Zhou Y. , Zhao Y. , Zhou Z. , Yang S. , Wang Z. Impact of transradial coronary procedures on radial artery. Angiology. IN PRESS.

Kim YO , Choi YJ , Kim JI , et al. The impact of intima-media thickness of radial artery on early failure of radiocephalic arteriovenous fistula in hemodialysis patients. J Korean Med Sci. 2006;21(2):284-289.

Parmar J. , Aslam M. , Standfield N. Pre-operative radial artery diameter predicts early failure of arteriovenous fistula (AVF) for haemodialysis. Eur J Vasc Endovasc Surg . 2007;33(1):113-115.

Elsharawy MA Prospective evaluation of factors associated with early failure of arteriovenous fistulae in hemodialysis patients. Vascular. 2006;14(2):70-74.

Liu BC , Li L. , Gao M. , Wang YL , Yu JR Microinflammation is involved in the dysfunction of arteriovenous fistula in patients with maintenance hemodialysis. Chin Med J (Engl). 2008;121(21):2157-2161.

Wakeyama T. , Ogawa H. , Iida H. , et al. Intima-media thickening of the radial artery after transradial intervention. An intravascular ultrasound study. J Am Coll Cardiol. 2003;41(7):1109-1114.

Wang HY , Meng Y. , Luo XJ , Wang QZ , Sun HS , Ruan YM Pathological changes of radial artery used for coronary artery bypass grafting and its related risk factors for intimal hyperplasia. Zhongua Wai Ke Za Zhi. 2006; 44(2):83-86.

Harley CR , Gandhi SK , Heien H. , McDonough K. , Nelson SP Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care. Expert Opin Pharmacother. 2008;9(5):669-676.

McDonald KJ , Jardine AG The use of fluvastatin in cardiovascular risk management. Expert Opin Pharmacother. 2008;9(8):1407-1414.

Soran H. , Durrington P. Rosuvastatin: efficacy, safety and clinical effectiveness. Expert Opin Pharmacother. 2008;9(12):2145-2160.

Athyros VG , Kakafika AI , Tziomalos K. , Karagiannis A. , Mikhailidis DP Pleiotropic effects of statins-clinical evidence. Curr Pharm Des. 2009;15(5):479-489.

Paraskevas KI , Stathopoulos V. , Mikhailidis DP Pleiotropic effects of statins: implications for a wide range of diseases. Curr Vasc Pharmacol. 2008;6(4):237-239.

Athyros VG , Kakafika AI , Tziomalos K. , Papageorgiou AA , Karagiannis A. Statins for the prevention of first or recurrent stroke. Curr Vasc Pharmacol. 2008;6(2):124-133.

Paraskevas KI , Athyros VG , Briana DD , Kakafika AI , Karagiannis A. , Mikhailidis DP Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures. Curr Drug Targets. 2007; 8(8):942-951.

Aydin U. , Ugurculan M. , Gungor F. , et al. Effects of atorvastatin on vascular intimal hyperplasia: an experimental rodent model. Angiology. 2009 ;60(3):370-377.

Westphal S. , Abletshauser C. , Luley C. Fluvastatin treatment and withdrawal: effects on endothelial function. Angiology. 2008;59(5):613-618.

Paraskevas KI , Hamilton G. , Mikhailidis DP Statins: an essential component in the management of carotid artery disease. J Vasc Surg. 2007 ;46(2):373-386.

Bots ML , Palmer MK , Dogan S. , et al, METEOR Study Group. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study . J Intern Med. 2009;265(6):698-707.

Ricioni G. , Bazzano LA , Bucciarelli T. , Mancini B. , di Ilio E. , D’Orazio N. Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: the Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study. Expert Opin Pharmacother . 2008;9(14):2403-2408.

Patti G. , Pasceri V. , Colonna G. , et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol . 2007;49(12):1272-1278.

Briguori C. , Visconti G. , Focaccio A. , et al. Novel Approaches for Preventing or Limiting Events (Naples) II Trial Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction. J Am Coll Cardiol. In press.

Paraskevas KI , Mikhailidis DP C-reactive protein (CRP): more than just an innocent bystander? Curr Med Res Opin. 2008 ;24(1):75-78.

Nakou ES , Liberopoulos EN , Milionis HJ , Elisaf MS The role of C-reactive protein in atherosclerotic cardiovascular disease: an overview. Curr Vasc Pharmacol. 2008;6(4):258-270.

Singh SK , Suresh MV , Voleti B. , Agrawal A. The connection between C-reactive protein and atherosclerosis. Ann Med. 2008;40(2):110-120.

Karha J. , Bavry AA , Rajagopal V. , Henderson MR , Ellis SG , Brener SJ Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimuseluting stent. Am J Cardiol. 2006;98(5):616-618.

Hong YJ , Jeong MH , Lim SY , et al. Relation of soft plaque and elevated preprocedural high-sensitivity Creactive protein levels to incidence of in-stent restenosis after successful coronary artery stenting. Am J Cardiol. 2006 ;98(3):341-345.

Palmerini T. , Marzocchi A. , Marrozzini C. , et al. Preprocedural levels of C-reactive protein and leukocyte counts predict 9-month mortality after coronary angioplasty for the treatment of unprotected left main coronary artery stenosis. Circulation. 2005;112(15):2332-2338.

Fatourou EM , Paraskevas KI , Seifalian AM , Hamilton G. , Mikhailidis DP The role of established and emerging risk factors in peripheral vascular graft occlusion. Expert Opin Pharmacother. 2007;8(7):901-911.

Owens CD , Ridker PM , Belkin M. , et al. Elevated Creactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. J Vasc Surg. 2007;45(1):2-9.

Abdellaoui A. , Al-Khaffaf H. C-reactive protein (CRP) as a marker in peripheral vascular disease. Eur J Vasc Endovasc Surg. 2007;34(1):18-22.

Tsiara S. , Elisaf M. , Mikhailidis DP Early vascular benefits of statin therapy. Curr Med Res Opin . 2003;19(6): 540-556.

Ilerigelen B. , Uresin Y. , San M. , et al. ; TULIPS Investigators. Efficacy and safety of extended-release fluvastatin in Turkish patients with hypercholesterolaemia: TULIPS (Turkish Lipid Study). Curr Med Res Opin. 2007;23(5):1093-1102.

Li JJ , Fang CH , Qian HY , Hu WL Time course of rapid C-reactive protein reduction by pravastatin in patients with stable angina. Angiology. 2006;57(1):1-7.